INDEPENDENT THINKING. TRACEABLE EVIDENCE.Research edition · 29 October 2026
Modern DosingTHE PRACTITIONER’S PERSPECTIVEA clearer view of
the peptide economy ↗
The provider file / Dossier 274
RESEARCH DOSSIER / NOT AN ENDORSEMENT

Nourish

A dated business research record, with the original field-level evidence labels kept intact.

Source snapshot: 2026-10-29. “Verified” below is the source dataset author’s label—not an independent license, safety, quality or clinical audit by Modern Dosing. These pages are excluded from search indexing until reviewed.
Positioning & service claimsverified

'Online Dietitian Covered by Insurance.' '94% of patients pay $0 out of pocket.' AI-native metabolic clinic positioning; treats 'GLP-1s, Gut health, + 21 more' conditions. Announced '$100M Series C to Reverse Chronic Disease with AI-Native Metabolic Clinic'.

Audienceread

Consumers with insurance coverage seeking dietitian-led metabolic/weight care; GLP-1 users needing nutrition support.

Pricing & termssnapshot

Insurance-billed; '94% of patients pay $0 out of pocket.' No self-pay GLP-1 medication pricing published on reviewed pages.

Clinical relationshipspartial

Registered-dietitian telehealth network; medical/metabolic clinic services advertised. Direct GLP-1 prescribing scope unconfirmed in this pass.

Pharmacy & fulfillmentnot_found

Not established; insurance-based care model, no pharmacy fulfillment named.

    Advertising snapshotpartial

    Google: '1 ad' header with 4 cards including Nourish, Inc. and two third-party advertisers (20 Oct 2026). Meta keyword ~110 results. LinkedIn: no attributable ads among 519 fuzzy matches. See dated channel evidence.

    Founding yearpartial

    Not captured in this pass (Y Combinator-backed).

    Founderspartial

    Co-founders Aidan, Sam Perkins and Stephanie (Y Combinator founder profile).

    Location & entity contextnot_found

    Not stated on pages reviewed.

      Search visibility samplenot_found

      Not assessed in this pass.

        THE MODERN DOSING WEEKLY

        The peptide news
        that changes your week.

        Evidence-backed developments. The moves that matter. What each means for your practice or business—in one weekly email.